TQF3250 capsules
Sponsors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions
Overweight/ObesityType 2 Diabetes Mellitus Combined With Overweight or Obesity
Phase 1
A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
RecruitingNCT07747857
Start: 2026-08-25End: 2027-07-01Target: 72Updated: 2026-08-28
A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention
Not yet recruitingNCT07798284
Start: 2026-09-01End: 2027-04-01Target: 80Updated: 2026-09-01